Ulivieri F M, Piodi L P, Taioli E, Lisciandrano D, Ranzi T, Vezzoli M, Cermesoni L, Bianchi P
Servizio di Radiologia, Ospedale Maggiore di Milano IRCSS, via F. Sforza 35, 20122 Milan, Italy.
Osteoporos Int. 2001;12(5):343-8. doi: 10.1007/s001980170100.
Reduced bone mineral density (BMD) has been reported in ulcerative colitis (UC), but there are no data concerning body composition (fat and lean mass) in such patients. We used whole body dual-energy X-ray absorptiometry (Hologic QDR 1000 W) at baseline and after 6 years of follow-up to study bone density, and fat and lean mass in 43 outpatients with mild UC (21 men, mean age 36 years, range 21-57 years, and 22 women, mean age 35 years, range 23-45 years at baseline; disease extent: 2 proctitis, 18 proctosigmoiditis, 8 left colitis, 5 substantial colitis, 10 pancolitis; mean disease duration 8 years, range 2-18 years; no hospitalization; few relapses during the follow-up) and 111 healthy volunteers matched by sex, age and body mass index. There were 5 drop-outs. We observed no significant difference in BMD, or fat and lean mass between the male patients and controls at baseline or after 6 years. The total lean mass (Z-score = -3.2, p = 0.001) and trunk lean mass (Z-score = -2.01, p = 0.03) of the female patients were lower than those of the controls at baseline, whereas their limb lean mass was higher at both the beginning and the end of the study (Z-score = 2.14, p = 0.03; Z-score = 2.8, p = 0.004, respectively). At baseline there was a significant negative correlation between lifetime steroid intake (enteral and parenteral) and lumbar spine BMD, obtained as whole body subregion (r = -0.53, p = 0.0006). After 6 years there was a significant negative correlation in women between whole body and lumbar spine BMD and both steroid intake (r = -0.53, p = 0.01; and r = -0.62, p = 0.003) and the number of relapses (r = -0.49, p = 0.02; and r = -0.44, p = 0.05). Mild UC thus does not represent a risk factor for osteopenia per se. The differences in lean mass between the female patients and controls do not seem to be clinically relevant.
已有报道称溃疡性结肠炎(UC)患者的骨矿物质密度(BMD)降低,但尚无关于此类患者身体成分(脂肪和瘦体重)的数据。我们在基线期及随访6年后,使用全身双能X线吸收仪(Hologic QDR 1000 W)对43例轻度UC门诊患者(21例男性,平均年龄36岁,范围21 - 57岁;22例女性,基线期平均年龄35岁,范围23 - 45岁;病变范围:2例直肠炎,18例直肠乙状结肠炎,8例左半结肠炎,5例广泛性结肠炎,10例全结肠炎;平均病程8年,范围2 - 18年;未住院治疗;随访期间复发次数少)及111名按性别、年龄和体重指数匹配的健康志愿者进行了骨密度、脂肪和瘦体重的研究。有5例退出研究。我们观察到,在基线期及6年后,男性患者与对照组之间的骨密度、脂肪和瘦体重均无显著差异。女性患者的总瘦体重(Z值 = -3.2,p = 0.001)和躯干瘦体重(Z值 = -2.01,p = 0.03)在基线期低于对照组,而其肢体瘦体重在研究开始和结束时均较高(Z值分别为2.14,p = 0.03;Z值为2.8,p = 0.004)。在基线期,终身类固醇摄入量(肠内和肠外)与作为全身子区域测得的腰椎骨密度之间存在显著负相关(r = -0.53,p = 0.0006)。6年后,在女性中,全身和腰椎骨密度与类固醇摄入量(r = -0.53,p = 0.01;r = -0.62,p = 0.003)及复发次数(r = -0.49,p = 0.02;r = -0.44,p = 0.05)之间均存在显著负相关。因此,轻度UC本身并不代表骨质减少的危险因素。女性患者与对照组之间瘦体重的差异似乎并无临床意义。